SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-136932
Filing Date
2020-12-17
Accepted
2020-12-17 17:18:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2038518d1_424b5.htm 424B5 222832
2 GRAPHIC logo.jpg GRAPHIC 14904
3 GRAPHIC tm2038518d1_424b5img001.jpg GRAPHIC 17436
  Complete submission text file 0001104659-20-136932.txt   268659
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251005 | Film No.: 201397078
SIC: 2834 Pharmaceutical Preparations